{"id":12608,"date":"2010-02-02T00:00:00","date_gmt":"2010-02-02T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/show093\/"},"modified":"2019-03-01T21:50:19","modified_gmt":"2019-03-01T21:50:19","slug":"show093","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/talk\/show093\/","title":{"rendered":"ePharma: What’s Working, What’s Not, & What’s Next"},"content":{"rendered":"

ePharma What’s Working, What’s Not, & What’s NextClick Here for Additional Resources<\/a><\/p>\n

The 9th Annual ePharma Summit<\/a><\/b> is geared up to offer a “Superbowl” of speakers and topics. John Mack will host and moderate a roundtable discussion with several of the Summit speakers and other invited guests from the ePharma Pioneer Club. The focus will be on What’s Working, What’s Not, & What’s Next.<\/p>\n

A topic of discussion will be the comments submitted to the FDA by the “Social Media Working Group” (SMWG) comprised of representatives from Amgen, AstraZeneca, Bristol-Myers Squibb, Millennium Pharmaceuticals, and sanofi-aventis U.S. (see A Pharma “Social Media Working Group” Submits Comments to FDA<\/a>).<\/p>\n